Abstract:Objective: We aimed to explore the feasibility of a novel apoptosis imaging agent (99)mTc-DCD, and to study the uptake of apoptotic cells in vitro and the distribution characteristics in normal Kunming mice. Methods: CBT-DEVD was dissolved in 2% DMSO, and DTPAA was added to make DTPA-CBT-DEVD (DCD) at room temperature for 30 minutes. Isolation and purification were performed by High Performance Liquid Chromatography (HPLC) purification. Moreover, mass spectrometer and ultraviolet spectrum were used to verify the chemical molecular structure. (99)mTc-DCD was made in combination with SnCl2 by direct labeling method and was used to detect the radiochemical purity and stability in vitro. The fresh prepared caspase-3 work buffe, 5U caspase-3 enzyme solution and 10 mu Ci(99)mTc-DCD solution were successively added, and mixed fully in the test tube. After 2 hours the reaction, the nanoparticles formed by copper mesh were observed by fluoroscopy. In addition, no caspase-3 was added in the control group. Subsequently. the supernatant was discarded and the radioactive count was measured. Besides, (99)mTc-DCD was added to the normal and cisplatin induced apoptotic Hela cell culture medium to observe the cell uptake in vitro. Each healthy Kunming mouse was injected with 0.2mCi(99)mTc-DCD from the tail vein, to perform SPECT imaging and study their biological distribution. Results: DCD was made after mixing with CBT-DEVD and DTPAA for 30 minutes, and its molecular weight was 1,370 g/mol by mass spectrometry. According to direct labeling method, the labeling rate of (99)mTc-DCD was 96%. After left 30 minutes and 120 minutes in fresh human serum, radiochemical purity was 91.5% and 90.8%, respectively. Besides, radiochemical purity was 90.0% after left 5 hours in normal saline and serum. (99)mTc-DCD reacted with caspase-3 enzyme for 2 hours in vitro, and transmission electron microscope showed that nanoparticles with an average diameter of about 500 nm formed. The radioactivity count of precipitation in the test tube was significantly about 3.1 times higher than that of the control tube. The cell uptake rate of (99)mTc-DCD in the apoptotic model of Hela cells was significantly higher than that in normal Hela cells (P < 0.01). In addition, cisplatin induced apoptosis of Hela cells was positive in term of caspase-3 expression. The biological distribution of (99)mTc-DCD in normal Kunming mice showed that the blood clearance rate of (99)mTc-DCD was faster and mainly excreted by the kidneys. Conclusion: (99)mTc-DCD, an apoptotic probe made by direct labeling method, could be self-assembled into nanoparticles after caspase-3 recognition and shearing, thus enriching the apoptotic cells and playing the role of signal amplification. In addition, (99)mTc-DCD labeled method was simple and convenient with high labeling rate, good stability and ideal cell uptake in vitro. The imaging in mice showed that it was mainly excreted through the kidneys. Therefore, (99)mTc-DCD was a potential imaging agent for apoptosis, which was expected to be used to evaluate the efficacy of radiotherapy and chemotherapy, and to detect the apoptotic state of ischemic tissues. Besides, further studies were performed to confirm its effect of clinical application.

Preparation of 99Tcm-Annexin V and in vitro study of its binding characteristics in dopaminergic apoptotic neurons

Preparation and bioevaluation of 88Tcm-HYNIC-Annexin B1 as a novel radiotracer for apoptosis detection

Preparation and Evaluation of ~(99)Tc~m-HYNICAnnexin Ⅴ for Apoptosis Imaging

Study of 99Mtc-Annexin V Uptake in Apoptotic Cell Models of Parkinson's Disease.

The Study on Tumor Cell Apoptotic Imaging in Vivo with 99Tcm-Hynic-annexin V in Mice Tumor-Bearing

Experimental study on tumor cell apoptosis imaging in vivo with 99Tcm-HYNIC-Annexin Ⅴ in mice tumor-bearing

Preparation and bioevaluation of 99m Tc-HYNIC-annexin B1 as a novel radioligand for apoptosis imaging

Preparation, in Vitro and in Vivo Evaluation of (99M)tc-Annexin B1: a Novel Radioligand for Apoptosis Imaging.

Preparation and bioevaluation of 99mTc-Annexin B1 as a novel radiotracer for apoptosis imaging

Preparation and in Vitro Evaluation of Human Recombinant Annexin V Using for Apoptosis

Annexin A5–Functionalized Nanoparticle for Multimodal Imaging of Cell Death

Preparation and Preliminary Evaluation of 125,131I Labeled Human Recombinant Annexin Ⅴ

Detection of Tumor Cell Apoptosis with 99Tcm-Rh-annexin V after Radiotherapy or Chemotherapy

Detection of Tumor Apoptotic Response in Vivo after a Single Dose of Chemotherapy with 99Tcm-Rh-annexin V

Synthesis And Imaging Of An Apoptotic Probe (99)Mtc-Dtpa-Cbt-Devd With Caspase-3 Controlled Self-Assembly Of Nanoparticles

Screening, purification, and identification of annexin B1 mutants with high phosphatidylserine-binding activity and reduced immunogenicity

Annexin A5-functionalized nanoparticles for in vivo dual modality imaging of apoptosis

Experimental study of myocardial apoptosis with 99Tcm-FM2 imaging

Experimental Study on Tumor Response to Chemotherapy with 18F-Sfb-annexin B1

Experimental Studies on Apoptosis Imaging of 153Sm-Annexin V

Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis.